Similar Papers

Paper Title
Journal
Date
Author
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.
Maria Schwaederle ... John Mendelsohn
Journal of Clinical Oncology | VOL. 33
Maria Schwaederle, et. al.Maria Schwaederle ... John Mendelsohn
24 Aug 2015
Unraveling molecular signatures and prognostic biomarkers in glioblastoma: a comprehensive study on treatment resistance and personalized strategies
Jinmin Xue ... Jing Zhu
Discover Oncology | VOL. 15
Jinmin Xue, et. al.Jinmin Xue ... Jing Zhu
04 Dec 2024
Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity.
Anna Heath ... Petros Pechlivanoglou
Medical Decision Making | VOL. 42
Anna Heath, et. al.Anna Heath ... Petros Pechlivanoglou
13 Jan 2022
Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment
Soumita Ghosh ... Mamatha Bhat
Gut | VOL. -
Soumita Ghosh, et. al.Soumita Ghosh ... Mamatha Bhat
22 Aug 2024
View more papers

More From: Journal of Hepatology

Paper Title
Journal
Date
Author
Introducing the Breakthrough Beyond the Journal series.
Vlad Ratziu
Journal of hepatology | VOL. 82
Vlad RatziuVlad Ratziu
01 Feb 2025
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Homie A Razavi ... Eli Zuckerman
Journal of Hepatology | VOL. -
Homie A Razavi, et. al.Homie A Razavi ... Eli Zuckerman
01 Feb 2025
MICROB-PREDICT works on identifying microbiome-based predictors and mechanisms of decompensated liver cirrhosis & ACLF, and develop personalised treatment strategies. Discover the project!
-
Journal of Hepatology | VOL. 82
--
01 Feb 2025
Hyodeoxycholic acid ameliorates cholestatic liver fibrosis by facilitating m6A-regulated expression of a novel anti-fibrotic target ETV4
Xiaoyong Xue ... Xiaojiaoyang Li
Journal of Hepatology | VOL. -
Xiaoyong Xue, et. al.Xiaoyong Xue ... Xiaojiaoyang Li
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.